Reston, Virginia’s PICS offers professional research software called Certas. PICS is charging a very reasonable $1,200 for Certas as the introductory price for an academic study with 30 participants. Larger projects might range as high as $30,000, depending on the scope of the research and the numbers of participants. It’s…more...
A few months back, we noted that AstraZeneca and PHT announced that e-diaries had supplied data for the July 2006 approval of Symbicort, a combination therapy for asthma. Recently we caught up with PHT to discuss the announcement. Its diaries were used in two pivotal trials that supplied the primary…more...
Arrowhead Electronic Healthcare has at least one very happy (and public) customer: Bayer. For those who don’t know the company, Arrowhead offers an electronic patient diary. The company is based in Texas and straddles the line between clinical research and health care. Headcount is up 20 percent since we last…more...
Microsoft recently announced a partnership with etrials in the electronic patient diary arena. The press release notes that etrials has been standardized around Microsoft since 1999. As some readers are aware, ClinPage has articulated the etrials position on Palm, which is that Palm has a great user interface and brand…more...
Many readers who missed the DIA Journal 2006, may want to check out an article with Lucy Abraham as the lead author. It’s in vol. 40, p. 259. Abraham is the manager of outcomes research for Pfizer in the UK. She and five other Pfizer co-authors, not to mention some…more...
Serge Bodart is the cofounder and CEO of Symfo, a small electronic patient diary company. Symfo may not be the largest company in the space, but he reports his business is brisk. And profitable. “We have been contracted by a few pharmaceutical companies to deploy clinical trials in eastern Europe—Russia,…more...
Astra-Zeneca’s Symbicort, an inhaled combination therapy for asthma, was approved by the FDA with the use of data from an electronic patient-reported outcome (ePRO) handheld device from PHT. It’s a major win for the Boston e-diary company. The approval also appears to be an additional sign that the FDA feels…more...
Depomed says its delivery technology allows drugs to remain in the stomach longer, keeping some compounds out of, say, the lower gastrointestinal tract. For those unfamiliar with the firm, Depomed is a small pharma specializing in repositioning old drugs. It looks for new indications for compounds that another company got…more...
The majority of electronic patient-reported outcome data (ePRO) in the pharmaceutical industry, we would venture, are collected on devices and software running on Palm. That’s a reflection of the industry’s assessment of Palm’s superior design. They are superbly easy devices to use. With the tap of a stylus or finger,…more...
A key developer of tools for interactive voice response systems has resolved its differences with industry giant ClinPhone. The pact was announced last week, and got buried in our inbox. Reading between the lines, and delving into other press releases on the HTS website, it looks the 2003 exclusive arrangement…more...
December 3, 2008
Ed Tourtellotte says slow, customized randomization is holding back the industry.
Two top firms, each specializing in different approaches to gathering patient experiences, will partner to help sponsors find the right technology.
At a user meeting later this month, invivodata will unveil a new device from a company other than Palm.
Using a tablet PC and the Apple phone, assiTek says larger screens can be helpful to science and sites.
Almac Clinical Technologies is adding electronic data capture to its expedited service offering.
A top technology supplier discusses the merits of combining two vital tools in a robust manner.
Organizations
Conferences
Info & Opinion
